Posted by Michael Wonder on 04 Jan 2019
Payers expect drug prices to rise 3 to 5 percent annually over the next three years
3 January 2019 - President Trump may be expecting a tremendous drop in prescription drug prices, but more than two dozen US payers think otherwise.
They foresee their per-unit acquisition costs rising between 3-5% annually over the next three years, according to a new survey by Cowen analysts.
Moreover, 13% of the payers attributed a substantial portion of those anticipated increases to more higher priced, newer medicines. By contrast, 40% of payers last year expected cost increases would be due to new therapies with high price tags.
